Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John Mosior
Observed names:
J.W. Mosior,
John W. Mosior,
John W. Mosior,
Mosior, J.,
Mosior, John W
Institution:
Moffitt Cancer Center
Observed institutions:
University of North Carolina at Chapel Hill,
Washington University in St. Louis,
Moffitt Cancer Center,
Texas A&M University,
The University of Texas Health Science Center at Houston
ORCID:
0000-0002-5649-7824
Observed ORCID:
0000-0002-5649-7824
OpenAlex ID:
A5038665167
An Active Role for the Ribosome in Determining the Fate of Oxidized mRNA
2014
·
Carrie L. Simms
, Benjamin H. Hudson
, et al.
·
Cell Reports
·
214
PDF
Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
2019
·
Elaine Ballinger
, John Mosior
, et al.
·
Science
·
72
PDF
Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides
2017
·
Kristina Najjar
, Alfredo Erazo-Oliveras
, et al.
·
Bioconjugate Chemistry
·
51
Discovery and design of molecular glue enhancers of CDK12–DDB1 interactions for targeted degradation of cyclin K
2024
·
Pompom Ghosh
, Maximilian Schmitz
, et al.
·
RSC Chemical Biology
·
12
PDF
Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas
2023
·
Samantha Ottavi
, Kelin Li
, et al.
·
ACS Medicinal Chemistry Letters
·
11
PDF
Redirecting raltitrexed from cancer cell thymidylate synthase to Mycobacterium tuberculosis phosphopantetheinyl transferase
2024
·
Amrita Singh
, Samantha Ottavi
, et al.
·
Science Advances
·
10
Structural insights into phosphopantetheinyl hydrolase PptH from Mycobacterium tuberculosis
2019
·
John Mosior
, Ronnie Bourland
, et al.
·
Protein Science
·
9
Structure–Activity and Structure–Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders
2026
·
Thiyagamurthy Pandurangan
, Solomon Tadesse Zeleke
, et al.
·
Journal of Medicinal Chemistry
·
2
Characterization of Phosphopantetheinyl Hydrolase from Mycobacterium tuberculosis
2021
·
Shilpika Pandey
, Amrita Singh
, et al.
·
Microbiology Spectrum
·
2
Author response for "Discovery and design of molecular glue enhancers of CDK12-DDB1 interactions for targeted degradation of cyclin K"
2024
·
Pompom Ghosh
, Maximilian Schmitz
, et al.
·
1
Abstract A053: Discovery and modular design of CDK12–DDB1 molecular glues for targeted Cyclin K degradation
2026
·
Thiyagamurthy Pandurangan
, Anna Iermolaieva
, et al.
·
Clinical Cancer Research
Therapeutic effect of menin inhibitors is reversible in AML treatment and could be enhanced by the targeting of differentiation associated chromatin complex
2025
·
Zhong Fan
, John Mosior
, et al.
·
Blood
PDF
Abstract B035: Targeting transcriptional elongation kinases prevents adaptation to KRASG12C inhibitors in both MAPK-dependent and -independent models of acquired resistance
2023
·
Yaakov E. Stern
, Pompom Ghosh
, et al.
·
Molecular Cancer Research
Abstract B028: CDK12/13 inhibition antagonizes resistance to KRASG12C inhibitors
2022
·
Yaakov E. Stern
, Pompom Ghosh
, et al.
·
Cancer Research
In Vitro and in Vivo Inhibition of the Mycobacterium tuberculosis Phosphopantetheinyl Transferase PptT by Amidinoureas
2022
·
Singh, A.
, Ling, Y.
, et al.
·
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Show more works
View as search
Works count:
18
Citation count:
384
H-index:
7
I10-index:
6
Year
Topic
Type
